Dr. Tracy EvansMD
Dermatology
at Pacific Skin and Cosmetic Dermatology San Francisco — San Francisco, CA
About
Dr. Tracy Evans is a board-certified dermatologist, fellowship-trained Mohs surgeon, and the founder of Pacific Skin and Cosmetic Dermatology. She graduated with honors from Vassar College, earning membership in Phi Beta Kappa. She then earned both a Master of Public Health and a medical degree from the University of Connecticut.
Before entering practice, Dr. Evans spent two years conducting skin cancer research for the National Institutes of Health. She completed her dermatology residency at Emory University in Atlanta and pursued fellowship training in Mohs micrographic surgery at the University of Pittsburgh Medical Center, earning certification from the American College of Mohs Micrographic Surgery. She has presented skin cancer outcomes research at national and international conferences. With over a decade of cosmetic dermatology experience, she regularly trains other injectors on advanced filler techniques. Her clinical focus balances the medical and aesthetic dimensions of skin health.
Education & Training
Undergraduate
Vassar College, BA with honors, Phi Beta Kappa
Medical School
University of Connecticut, MPH and MD
Residency
Dermatology residency, Emory University
Fellowship
Mohs micrographic surgery fellowship, University of Pittsburgh Medical Center
Certifications
Conditions Treated
Who is Dr. Evans right for?
Dr. Evans is well suited for patients who need surgical skin cancer care, including Mohs micrographic surgery. Adults seeking a dermatologist with deep expertise in both medical and cosmetic skin health will find her approach thorough. Patients interested in advanced injectable techniques benefit from her extensive training and experience teaching other providers. Those managing complex skin conditions alongside cosmetic concerns can address both in a single practice.
Similar Doctors Nearby
Dr. Cristian GonzalezMD
Autoimmune blistering diseases, Rheumatologic-dermatologic diseases, Severe drug eruptions +22 more
Dr. Nazaneen HomaifarMD
obstetric conditions, gynecologic conditions, routine obstetrics +1 more
Dr. Adina KellerMD
menopause, perimenopause, gynecologic cancer prevention +2 more
Frequently Asked Questions
Dr. Evans specializes in Mohs micrographic surgery, skin cancer treatment, and cosmetic dermatology. She holds board certification in dermatology and fellowship certification from the American College of Mohs Micrographic Surgery. Her clinical focus covers both the medical and aesthetic dimensions of skin health.
Yes. Dr. Evans completed her Mohs surgery fellowship at the University of Pittsburgh Medical Center. The American College of Mohs Micrographic Surgery certified her following that training. She performs Mohs surgery in-office at the San Francisco location.
Dr. Evans earned her MPH and MD at the University of Connecticut. She completed her dermatology residency at Emory University in Atlanta. She then trained in Mohs micrographic surgery at the University of Pittsburgh Medical Center.
Yes. Dr. Evans spent two years conducting skin cancer research for the National Institutes of Health before entering clinical practice. She has also presented skin cancer outcomes research at national and international conferences.
Yes. Dr. Evans has over a decade of cosmetic dermatology experience. She offers injectables including BOTOX, Dysport, Daxxify, and Xeomin, as well as fillers, laser treatments, and other cosmetic procedures. She also trains other injectors on advanced filler techniques.
Dr. Evans treats skin cancer, acne, rosacea, eczema, psoriasis, hyperpigmentation, melasma, alopecia, and a wide range of other medical skin conditions. She also addresses cosmetic concerns including wrinkles, volume loss, and skin texture. Her practice covers both surgical and non-surgical care.
Dr. Evans sees patients at Pacific Skin and Cosmetic Dermatology in San Francisco and at the Corte Madera location in Marin County. She serves as Medical Director at both sites.
Doctor profile last updated March 21, 2026
